Thе role of zinc in the development of cardiovascular complications in patients with Graves’ disease

Thе role of zinc in the development of cardiovascular complications in patients with Graves’ disease

Backgraund. The development of cardiovascular complications in patients with diffuse-toxic goiter (DTZ) is an actual problem of thyroidology. (SSS) in patients with DTZ. Aims. To assess the contribution of zinc deficiency in the formation of cardiovascular complications in patients with Graves di...

Full description

Bibliographic Details
Main Authors:	Lyudmila V. Kvitkova, Daria S. Vinichenko, Daria A. Borodkina, Sergey F. Zinchuk, Natalia V. Fomina, Sergey S. Maximov
Format:	Article
Language:	Russian
Published:	Endocrinology Research Centre 2018-02-01
Series:	Клиническая и экспериментальная тиреоидология
Subjects:	zinc graves’ disease atrial fibrillation chronic heart failure
Online Access:	https://cet-endojournals.ru/ket/article/viewFile/8270/7150

Similar Items

Prediction model for thyrotoxic atrial fibrillation: a retrospective study
by: Daria Aleksandrovna Ponomartseva, et al.
Published: (2021-07-01)

Graves disease and atrial fibrillation
by: Bello-Espinosa Ariel, et al.
Published: (2010-06-01)

SNP Ser38Gly in the β-subunit of potassium channel gene KCNE1 and thyrotoxic cardiomyopathy in patients with Graves’ disease
by: Alina Yur'evna Babenko, et al.
Published: (2015-07-01)

Life-threatening complications of high doses of intravenous methylprednisolone for treatment of Graves’ orbitopathy
by: Dorota Walasik-Szemplińska, et al.
Published: (2019-12-01)

ВОЗРАСТНЫЕ ОСОБЕННОСТИ ДИФФУЗНОГО ТОКСИЧЕСКОГО ЗОБА. СЛУЧАЙ ИЗ ПРАКТИКИ
by: Л. М. Фархутдинова, et al.
Published: (2015-06-01)

Symptoms in Adults with Atrial Fibrillation Seeking Care in Emergency Department
by: Gonia, Regina, et al.
Published: (2017)

Propafenone effect on inotropic myocardial function in patients with recurrent atral fibrillation
by: I. G. Fomina, et al.
Published: (2006-06-01)

Patogenia y tratamiento médico de la orbitopatía de graves
by: V. Soledad Hidalgo, Dra.
Published: (2010-11-01)

The fate of patients after failed epicardial ablation of atrial fibrillation
by: Giuseppe Nasso, et al.
Published: (2021-09-01)

PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN ATRIAL FIBRILLATION - RAT POISON OR NEW ORAL ANTICOAGULANTS: DO WE HAVE A CHOICE, AND SHOULD WE BE AFRAID TO MAKE IT? FIRST CLINICAL EXPERIENCE WITH RIVAROXABAN IN NIZHNY NOVGOROD
by: L. Y. Koroleva, et al.
Published: (2015-12-01)

PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN ATRIAL FIBRILLATION - RAT POISON OR NEW ORAL ANTICOAGULANTS: DO WE HAVE A CHOICE, AND SHOULD WE BE AFRAID TO MAKE IT? FIRST CLINICAL EXPERIENCE WITH RIVAROXABAN IN NIZHNY NOVGOROD
by: L. Y. Koroleva, et al.
Published: (2015-09-01)

Levels of Thyroid Autoantibodies in Patients with Graves’ Disease and Graves’ Ophtalmopathy - Original Article
by: Mihail Boyanov, et al.
Published: (2010-09-01)

Comparison of Clinical and Biochemical Parameters in Atrial Fibrillation Patients Using Dabigatran and Rivoraxaban and Their Relationship with Complications
by: İrfan Aydın, et al.
Published: (2020-03-01)

Th1/Th2 Cytokines in Patients with Graves' Disease with or without Ophthalmopathy
by: Fatemeh Esfahanian, et al.
Published: (2013-06-01)

Successful carotid thrombus aspiration, middle cerebral mechanical thrombectomy, and axillary artery clot disruption attempt in a patient with acute ischemic stroke and critical upper limb ischemia
by: Anton A. Khilchuk, et al.
Published: (2018-02-01)

A new method of left atrial appendage occlusion for the prevention of thromboembolic complications in patients with atrial fibrillation during coronary artery bypass grafting
by: Yu. Yu. Vecherskiy, et al.
Published: (2020-09-01)

RIVAROXABAN IN THE PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH ATRIAL FIBRILLATION
by: M. Yu. Gilyarov
Published: (2015-12-01)

The role of inflammatory markers in atrial fibrillation: a review
by: S. V. Grigoryan, et al.
Published: (2012-10-01)

Prevalence of Graves′ ophthalmopathy in patients with Graves′ disease presenting to a referral centre in north India
by: Sagili Vijaya Bhaskar Reddy, et al.
Published: (2014-01-01)

An Unusual Complication of Transseptal Puncture
by: Ajay Pillai, MD, et al.
Published: (2021-01-01)

Effect of Prophylactic Low Dose of Methylprednisolone on Postoperative New Atrial Fibrillation and Early Complications in Patients with Severe LV Dysfunction Undergoing Elective Off-Pump Coronary Arte
by: Seyed Jalil Mirhosseini, et al.
Published: (2011-05-01)

Corticosteroid Pulse Therapy for Graves' Ophthalmopathy Reduces the Relapse Rate of Graves' Hyperthyroidism
by: Rosario Le Moli, et al.
Published: (2020-06-01)

Inotropic myocardial function dynamics in patients with recurrent atrial fibrillation
by: N. E. Gaidamakina, et al.
Published: (2006-06-01)

Clinical practices of the management of nonvalvular atrial fibrillation and outcome of treatment: A representative prospective survey in tertiary healthcare centers across Turkey
by: Bülent Özin, et al.
Published: (2018-03-01)

Atrial fibrillation after cardiac surgery: Prevention and management: The Australasian experience
by: Mohammed Alawami, et al.
Published: (2018-01-01)

Catheter, surgical, or hybrid procedure: what future for atrial fibrillation ablation?
by: Giuseppe Nasso, et al.
Published: (2021-06-01)

Cardioform Septal Occluder in the Management of Cardiac Tamponade as a Complication of LAA Closure
by: Nabil Braiteh, MD, et al.
Published: (2020-06-01)

Pathophysiology of atrial fibrillation: From initiation to maintenance
by: Masatoshi Yamazaki, et al.
Published: (2012-06-01)

CHANGE OF LOCAL MYOCARDIAL CONTRACTILITY DUE TO SELECTION OF DIFFERENT ARRHYTHMIA TREATMENT STRATEGIES IN PATIENTS WITH ISCHEMIC HEART DISEASE AND PAROXYSMAL ATRIAL FIBRILLATION
by: V. I. Podzolkov, et al.
Published: (2015-09-01)

Autonomous nervous system and cardiac arrhythmias in patients with recurrent atrial fibrillation: long-term electrocardiogram monitoring data
by: A. V. Vetluzhsky, et al.
Published: (2007-08-01)

Anticoagulation Quality and Complications of using Vitamin K Antagonists in the Cardiac Surgery Outpatient Clinic
by: Mário Augusto Cray da Costa, et al.

Delayed sinus rhythm restoration after thoracoscopic left atrium fragmentation (а report of two cases)
by: Sergey A. Vachev, et al.
Published: (2020-12-01)

Acute atrial fibrillation complicating organophosphorus poisoning
by: Monika Maheshwari, et al.
Published: (2017-01-01)

UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTION
by: E. A. Protasova, et al.
Published: (2015-12-01)

The content of selenium, antibodies to TSH receptor and their correlation in patients with Graves’ disease complicated by autoimmune ophthalmopathy
by: Yu.V. Buldyhina, et al.
Published: (2020-08-01)

EXPERIENCE IN THE USE OF ORAL ANTICOAGULANTS IN OUTPATIENT CLINICS
by: T. V. Voskresenskaya, et al.
Published: (2017-11-01)

Graves’ ophthalmopathy – thyroid eye disease
by: Dagna Siedlecka, et al.
Published: (2019-08-01)

Atrial Fibrillation Ablation: Indications, New Advances, and Complications
by: Chang-Sheng Ma, MD
Published: (2016-02-01)

Clinical characteristics of patients with atrial flutter before radiofrequency ablation
by: Daiana Pavlova, et al.
Published: (2020-09-01)

ATRIAL FIBRILLATION: FUNCTIONAL CLASSIFICATION
by: A. V. Germanov, et al.
Published: (2020-11-01)